RxDoctor Payments Data

Lester Johnston, MD

Internal Medicine · Washington, GANPI 1518975754

Payments from drug & device makers

$2,220in general payments, 2019–2025

Across 145 payments — averaging $15.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$824
  • Sanofi-aventis U.S. LLC$236
  • AstraZeneca$234
  • Lilly USA, LLC$209
  • AbbVie$153
  • Boehringer Ingelheim$137
  • plus $428 from 8 others

What the payments were for

  • Food & beverage$2,17498%
  • Education$462%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,220 in reported general payments places this provider in the 75th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$30,539
Medicare patients
121
Services billed
285

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin381$358,665
OzempicSemaglutide299$344,604
MounjaroTirzepatide234$250,340
EliquisApixaban120$123,759
TrulicityDulaglutide38$46,298
XareltoRivaroxaban39$43,534
Abilify MaintenaAripiprazole14$39,625
Breztri AerosphereBudesonide/Glycopyr/Formoterol40$37,348
Tresiba Flextouch U-200Insulin Degludec26$33,572
FarxigaDapagliflozin Propanediol46$33,454
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$32,701
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog18$18,058
LinzessLinaclotide18$16,074
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog27$14,404
Breo ElliptaFluticasone/Vilanterol31$12,938

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$137$362,060406 claims
Novo NordiskOzempic$824$344,604299 claims
Lilly USA, LLCMounjaro, Trulicity$209$296,638272 claims
PfizerEliquis$96$123,759120 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort$234$77,401112 claims
Johnson & JohnsonXarelto$94$43,53439 claims
AbbVieLinzess$153$16,07418 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$236$12,34015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,311 internal medicine providers in Georgia.

Other internal medicine in Washington

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →